Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevnar 2-dose versus 2+1 infant vaccination study on pneumococcal carriage and herd immunity
NL-OMON26724Active, not recruiting
- Sponsor
- UMC Utrecht Department of Pediatric Immunology
- Start
- Jun 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of pneumococcal 7-valent conjugate vaccine in invasive pneumococcal disease (IPD) (3 arms), sponsored by UMC Utrecht Department of Pediatric Immunology. Primary endpoints: Pneumococcal nasopharyngeal carriage in children and Pneumococcal nasopharyngeal carriage in family members. Started Jun 2005; status: active, not recruiting.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on NL-OMON26724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26724.